16.9701.74% ( +0.290 )
Delay Closed: Nov 5, 16:08:17Q3 FY2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: SINOPHARM(01099) the Revenue is 169.43 B (+6.58%);the EBIT is 4.93 B (+9.46%);the EPS is 3.68 (+2.36%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
169.43B6.58%
----
----
EBIT
4.93B9.46%
----
----
EPS
3.67812.36%
----
----
Upcoming earnings report - Annual FY2026
Available dateMar 25, 2027
Estimate Revenue683.49 B
Estimate EBIT--
Estimate EPS2.8118
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
